AU4165493A - Sustained release pharmaceutical composition - Google Patents
Sustained release pharmaceutical compositionInfo
- Publication number
- AU4165493A AU4165493A AU41654/93A AU4165493A AU4165493A AU 4165493 A AU4165493 A AU 4165493A AU 41654/93 A AU41654/93 A AU 41654/93A AU 4165493 A AU4165493 A AU 4165493A AU 4165493 A AU4165493 A AU 4165493A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical composition
- sustained release
- release pharmaceutical
- sustained
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU41654/93A AU668174C (en) | 1993-06-30 | Sustained release pharmaceutical composition | |
NZ24816693A NZ248166A (en) | 1993-06-30 | 1993-07-16 | Sustained-release pharmaceutical pellet composition comprising a core and a coating which is partially soluble at a high acidic ph, the active ingredient being absorbable from the intestine over an extended time |
CN 94115992 CN1107331A (en) | 1993-06-30 | 1994-06-30 | Sustained release pharmaceutical composition |
CNA021219125A CN1468597A (en) | 1993-06-30 | 2002-05-24 | Continuous released medical composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU41654/93A AU668174C (en) | 1993-06-30 | Sustained release pharmaceutical composition |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU47732/90A Addition AU617573C (en) | 1989-01-06 | 1990-01-05 | Sustained release pharmaceutical composition |
Publications (3)
Publication Number | Publication Date |
---|---|
AU4165493A true AU4165493A (en) | 1995-02-16 |
AU668174B2 AU668174B2 (en) | 1996-04-26 |
AU668174C AU668174C (en) | 1997-09-25 |
Family
ID=
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6143328A (en) * | 1993-07-27 | 2000-11-07 | Euro-Celtique, S.A. | Sustained release compositions and a method of preparing pharmaceutical compositions |
US6294195B1 (en) | 1991-12-24 | 2001-09-25 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
US6399096B1 (en) | 1995-09-22 | 2002-06-04 | Euro-Celtique S.A. | Pharmaceutical formulation |
US6806294B2 (en) | 1998-10-15 | 2004-10-19 | Euro-Celtique S.A. | Opioid analgesic |
US7846476B2 (en) | 2001-05-02 | 2010-12-07 | Purdue Pharma L.P. | Once-a-day oxycodone formulations |
US9655893B2 (en) | 2001-05-02 | 2017-05-23 | Purdue Pharma L.P. | Once-a-day oxycodone formulations |
US9675611B1 (en) | 1999-10-29 | 2017-06-13 | Purdue Pharma L.P. | Methods of providing analgesia |
US10022368B2 (en) | 2000-10-30 | 2018-07-17 | Purdue Pharma L.P. | Methods of manufacturing oral formulations |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294195B1 (en) | 1991-12-24 | 2001-09-25 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
US6572885B2 (en) | 1991-12-24 | 2003-06-03 | Euro-Celtique, S.A. | Orally administrable opioid formulations having extended duration of effect |
US6143328A (en) * | 1993-07-27 | 2000-11-07 | Euro-Celtique, S.A. | Sustained release compositions and a method of preparing pharmaceutical compositions |
US6399096B1 (en) | 1995-09-22 | 2002-06-04 | Euro-Celtique S.A. | Pharmaceutical formulation |
US6806294B2 (en) | 1998-10-15 | 2004-10-19 | Euro-Celtique S.A. | Opioid analgesic |
US9675611B1 (en) | 1999-10-29 | 2017-06-13 | Purdue Pharma L.P. | Methods of providing analgesia |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US10076516B2 (en) | 1999-10-29 | 2018-09-18 | Purdue Pharma L.P. | Methods of manufacturing oral dosage forms |
US10022368B2 (en) | 2000-10-30 | 2018-07-17 | Purdue Pharma L.P. | Methods of manufacturing oral formulations |
US9655894B2 (en) | 2001-05-02 | 2017-05-23 | Purdue Pharma L.P. | Once-A day oxycodone formulations |
US9655893B2 (en) | 2001-05-02 | 2017-05-23 | Purdue Pharma L.P. | Once-a-day oxycodone formulations |
US7846476B2 (en) | 2001-05-02 | 2010-12-07 | Purdue Pharma L.P. | Once-a-day oxycodone formulations |
US10660886B2 (en) | 2001-05-02 | 2020-05-26 | Purdue Pharma L.P. | Oxycodone formulations |
Also Published As
Publication number | Publication date |
---|---|
AU668174B2 (en) | 1996-04-26 |
CN1107331A (en) | 1995-08-30 |
CN1468597A (en) | 2004-01-21 |
NZ248166A (en) | 1995-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6216296A (en) | Pharmaceutical compositions | |
AUPN411195A0 (en) | Medicinal composition | |
AU6740298A (en) | Pharmaceutical composition | |
AU7590096A (en) | Drug composition | |
AU3716193A (en) | Pharmaceutical compositions | |
AU5155096A (en) | Pharmaceutical composition | |
GB9316580D0 (en) | Pharmaceutical composition | |
AU5274096A (en) | Pharmaceutical compositions | |
AU2531295A (en) | Pharmaceutical composition | |
AU5943990A (en) | Sustained release pharmaceutical compositions | |
AU9343098A (en) | Pharmaceutical composition | |
AU7275894A (en) | Imidazolylalkylamine derivative and pharmaceutical composition thereof | |
AU2392492A (en) | Pharmaceutical composition | |
CA2100836A1 (en) | Pharmaceutical Composition | |
AU7661994A (en) | Photopolymerisable composition | |
AU6690394A (en) | Imidazolylquinoxalinedione derivative and pharmaceutical composition thereof | |
GB9318880D0 (en) | Pharmaceutical composition | |
AU668174C (en) | Sustained release pharmaceutical composition | |
AU4165493A (en) | Sustained release pharmaceutical composition | |
AU6814496A (en) | Pharmaceutical composition | |
AU3528593A (en) | Pharmaceutical composition | |
AUPM303393A0 (en) | Pharmaceutical composition | |
AU617573C (en) | Sustained release pharmaceutical composition | |
AU741226C (en) | Pharmaceutical composition | |
AU723097C (en) | Pharmaceutical composition |